Commentary by Emily Poulin and Kevin Haigis: No back seat for a progression event— K-RAS as a therapeutic target in CRC

We invite you to read Emily Poulin and Kevin Haigis's recent commentary on K-RAS: No back seat for a progression event—K-RAS as a therapeutic target in CRC.

http://genesdev.cshlp.org/content/31/4/333.abstract